ipatasertib (Compound)

Synonyms:Ipatasertib, GDC-0068, 1001264-89-6, Ipatasertib (GDC-0068), UNII-524Y3IB4HQ, RG7440, GDC0068, GDC 0068, RG-7440, GDC-0068 (RG7440), 524Y3IB4HQ, CHEMBL2177390, (S)-2-(4-chlorophenyl)-1-(4-((5R,7R)-7-hydroxy-5-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)piperazin-1-yl)-3-(isopropylamino)propan-1-one, RG 7440, (2S)-2-(4-Chlorophenyl)-1-[4-[(5R,7R)-6,7-dihydro-7-hydroxy-5-methyl-5H-cyclopentapyrimidin-4-yl]-1-piperazinyl]-3-[(1-methylethyl)amino]-1-propanone, (2S)-2-(4-chlorophenyl)-1-[4-[(5R,7R)-7-hydroxy-5-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(propan-2-ylamino)propan-1-one, C24H32ClN5O2, (2s)-2-(4-Chlorophenyl)-1-{4-[(5r,7r)-7-Hydroxy-5-Methyl-6,7-Dihydro-5h-Cyclopenta[d]pyrimidin-4-Yl]piperazin-1-Yl}-3-(Propan-2-Ylamino)propan-1-One, 1-Propanone, 2-(4-chlorophenyl)-1-(4-((5R,7R)-6,7-dihydro-7-hydroxy-5-methyl-5H-cyclopentapyrimidin-4-yl)-1-piperazinyl)-3-((1-methylethyl)amino)-, (2S)-, Ipatasertib [USAN:INN], MFCD22124514, 1-Propanone, 2-(4-chlorophenyl)-1-[4-[(5R,7R)-6,7-dihydro-7-hydroxy-5-methyl-5H-cyclopentapyrimidin-4-yl]-1-piperazinyl]-3-[(1-methylethyl)amino]-, (2S)-, GDC0068 di-HCl, Ipatasertib (USAN/INN), GDC-0068 di-HCl, Ipatasertib; GDC-0068, RG-7440 di-HCl, SCHEMBL191659, GTPL7887, CHEBI:95089, AOB87386, EX-A2077, BDBM50398379, NSC767898, NSC781451, NSC800986, NSC832484, s2808, ZINC68250459, AKOS025396463, BCP9000712, CCG-269312, CS-0975, DB11743, NSC-767898, NSC-781451, NSC-800986, NSC-832484, NCGC00346714-01, (2S)-2-(4-Chlorophenyl)-1-(4-((5R,7R)-7-hydroxy-5-methyl-6,7-dihydro-5H-cyclopenta(d)pyrimidin-4-yl)piperazin-1-yl(-3-((propan-2-yl)amino)propan-1-one, 2-(4-chlorophenyl)-1-(4-(7-hydroxy-5-methyl-6,7-dihydro-5H-cyclopenta(d)pyrimidin-4-yl)piperazin-1-yl)-3-(isopropylamino)propan-1-one, AC-28420, AS-17027, HY-15186, QC-10488, BCP0726000195, AB0033076, X6541, J3.478.537F, D10641, Q27078088, (2S)-2-(4-chlorophenyl)-1-[4-[(5R,7R)-7-hydroxy-5-methyl-6,7-dihydro-5H-cyclopenta[e]pyrimidin-4-yl]piperazin-1-yl]-3-(propan-2-ylamino)propan-1-one, 0RF

Pubchem:PUBCHEM:24788740

Id:a1f3c723-9841-5ff7-a7c4-a6a8607997a5

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View ipatasertib's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for ipatasertib.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with ipatasertib.

Results found

Linked to

	Label	Description
	ipatasertib (ac525b3f-ef5e-4219-bb84-0c702d78a94b) Collection (Entity type)	Metadatata for ipatasertib
	ipatasertib in similarity relationship with Everolimus Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	ipatasertib positively regulates TM4SF1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	ipatasertib negatively regulates DDIT4 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	ipatasertib negatively regulates JMJD6 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	ipatasertib positively regulates PLAU Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	ipatasertib positively regulates F2R Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	ipatasertib positively regulates PLAT Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	ipatasertib positively regulates RPS4Y1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	ipatasertib negatively regulates FTH1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS